Prospective Evaluation of Self-Testing to Increase Screening
Launched by BAYLOR COLLEGE OF MEDICINE · Mar 29, 2019
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. Using mailed self-sampling kits to test for high-risk human papillomavirus (HPV), the virus that causes cervical cancer, may overcome multiple barriers to clinic-based screening. This study is a randomized controlled trial to compare the effectiveness of three outreach interventions to increase primary screening participation and clinical follow-up among underscreened women a in a safety net health system. The three strategies that will be evaluated are: 1) telephone...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • no history of hysterectomy or cervical cancer
- • no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
- • patient of Harris Health System in Harris County (Houston), Texas
- • have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
- • be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months
- Exclusion Criteria:
- • no valid telephone contact information
- • unable to communicate in English or Spanish\*
- • currently pregnant
- • history of cervical dysplasia in the past 3.5 years
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Jane R Montealegre, PhD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials